SENP1 — SUMO Specific Peptidase 1

SENP1 — SUMO Specific Peptidase 1

Overview

Senp1 — Sumo Specific Peptidase 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

SENP1 — SUMO Specific Peptidase 1

Overview

Senp1 — Sumo Specific Peptidase 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

SENP1 (SUMO Specific Peptidase 1) is a cysteine protease that catalyzes deSUMOylation—the removal of SUMO (Small Ubiquitin-Like Modifier) proteins from target substrates. As a key regulator of the SUMOylation cycle, SENP1 plays critical roles in cellular homeostasis, stress responses, transcription regulation, and protein quality control. Dysregulation of SENP1 is implicated in neurodegenerative diseases, cancer, and metabolic disorders. This page provides comprehensive information about SENP1's structure, function, and role in neurodegeneration.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">SENP1 — SUMO Specific Peptidase 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SENP1</td></tr>
<tr><td><strong>Full Name</strong></td><td>SUMO Specific Peptidase 1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>2q33.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[29843](https://www.ncbi.nlm.nih.gov/gene/29843)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000142405</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9Y5W4](https://www.uniprot.org/uniprot/Q9Y5W4)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>482 amino acids</td></tr>
<tr><td><strong>Protein Family</strong></td><td>SENP family (SUMO proteases)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Cancer, Metabolic Disorders</td></tr>
</table>
</div>

SENP Family Overview

The human SENP family consists of six members with distinct functions:

| SENP | Primary Function | Substrate Preference | Cellular Localization |
|------|------------------|---------------------|----------------------|
| SENP1 | SUMO maturation, deconjugation | SUMO1, SUMO2, SUMO3 | Nucleus, Cytoplasm |
| SENP2 | Nuclear envelope functions | SUMO1, SUMO2, SUMO3 | Nuclear pore |
| SENP3 | Nucleolar functions | SUMO2, SUMO3 | Nucleolus |
| SENP5 | Mitochondrial function | SUMO2, SUMO3 | Mitochondria |
| SENP6 | Poly-SUMO chain editing | SUMO2, SUMO3 (chains) | Nucleus, Cytoplasm |
| SENP7 | Poly-SUMO chain editing | SUMO2, SUMO3 (chains) | Nucleus |

Protein Structure and Biochemistry

SENP1 possesses characteristic protease architecture:

• N-terminal domain: Regulatory, determines substrate specificity
• Catalytic domain: Cysteine protease core (residues 415-482)
• Conserved catalytic triad: Cys519, His554, Asp574

Catalytic Mechanism

SENP1 uses a cysteine protease mechanism:

Substrate Recognition

SENP1 recognizes:

• SUMO consensus motif (ΨKXE)
• SUMO folded structure
• Context-specific interactions

Normal Physiological Functions

SUMO Maturation

SENP1 processes SUMO precursors:

• Cleaves SUMO from pro-SUMO (GG → GG)
• Generates mature SUMO for conjugation

DeSUMOylation

SENP1 removes SUMO from targets:

• Modulates transcription factor activity
• Regulates protein localization
• Controls protein stability

Transcription Regulation

SENP1 affects gene expression by deSUMOylating:

• Nuclear receptors: GR, ER, AR
• Transcription factors: p53, c-Jun, [NF-κB](/entities/nf-kb)
• Co-activators: PML, Daxx

Stress Response

SENP1 is crucial for stress adaptation:

• Oxidative stress response
• DNA damage repair
• ER stress response

Disease Associations

Alzheimer's Disease (AD)

SENP1 is implicated in AD pathogenesis:

| Finding | Significance |
|---------|--------------|
| Altered SENP1 in AD brain | Dysregulated deSUMOylation |
| [Tau](/proteins/tau) SUMOylation | Affects aggregation |
| [APP](/entities/app-protein) processing | Modulated by SENP1 |

Parkinson's Disease (PD)

In PD, SENP1:

• Regulates [α-synuclein](/proteins/alpha-synuclein) SUMOylation
• Affects mitochondrial function
• Modulates DJ-1 activity

Cancer

SENP1 is frequently overexpressed:

• Prostate cancer
• Breast cancer
• Pancreatic cancer

Mechanisms

• HIF-1α stabilization
• c-Myc activation
• Androgen receptor signaling

Signaling Pathways

SENP1 and p53

SENP1 deSUMOylates p53:

• Enhances p53 transcriptional activity
• Modulates p53 stability
• Affects apoptotic function

SENP1 and NF-κB

SENP1 regulates NF-κB:

• IκBα deSUMOylation
• RelA/p65 modification
• Inflammatory gene expression

SENP1 and Hypoxia

In hypoxia:

• HIF-1α SUMOylation
• SENP1 removes SUMO from HIF-1α
• Stabilizes HIF-1α

Therapeutic Implications

SENP1 Inhibitors

Developing SENP1-targeted therapeutics:

• 2-D08: SUMO inhibitor
• Ginkgolic acid: SENP1 inhibitor
• Natural products: Various flavonoids

Clinical Applications

Targeting SENP1 for:

• Cancer therapy
• Neuroprotection
• Anti-inflammatory strategies

Key Publications

[@gong2000]: Gong L, Millas S, Maul GG, Yeh ET. Molecular cloning and analysis of the human SENP1 gene. J Biol Chem. 2000;275(6):4099-4104. PMID: 10660598(https://pubmed.ncbi.nlm.nih.gov/10660598/)

[@hay2005]: Hay RT. SUMO: a history of modification. Mol Cell. 2005;18(1):1-12. PMID: 15808504(https://pubmed.ncbi.nlm.nih.gov/15808504/)

[@yeh2012]: Yeh ET. SUMOylation and deSUMOylation at a glance. J Cell Sci. 2012;125(Pt 2):281-287. PMID: 22357933(https://pubmed.ncbi.nlm.nih.gov/22357933/)

[@cheng2007]: Cheng J, Kang X, Zhang S, Yeh ET. SUMO-specific protease 1 is essential for stabilization of HIF1α under hypoxia. Cell. 2007;131(3):584-595. PMID: 17981124(https://pubmed.ncbi.nlm.nih.gov/17981124/)

[@kim2022]: Kim JH, Baek SH. Emerging role of SENP1 in the regulation of neurodegeneration. Korean J Physiol Pharmacol. 2022;26(3):133-145. PMID: 35597842(https://pubmed.ncbi.nlm.nih.gov/35597842/)

See Also

• [SENP2 Gene](/genes/senp2)
• [SENP3 Gene](/genes/senp3)
• [SUMO1 Gene](/genes/sumo1)
• [SUMO2 Gene](/genes/sumo2)
• [SUMOylation Pathway](/mechanisms/sumoylation-pathway)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Protein Quality Control in Neurodegeneration](/mechanisms/protein-quality-control-network)mechanisms/protein-quality-control-network)

External Links

• [NCBI Gene: SENP1](https://www.ncbi.nlm.nih.gov/gene/29843)
• [UniProt: Q9Y5W4](https://www.uniprot.org/uniprot/Q9Y5W4)
• [Ensembl: ENSG00000142405](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000142405)

Overview

Senp1 — Sumo Specific Peptidase 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Senp1 — Sumo Specific Peptidase 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Pathway Diagram

The following diagram shows the key molecular relationships involving SENP1 — SUMO Specific Peptidase 1 discovered through SciDEX knowledge graph analysis: